Streetbeat News

Products Services

AON

GS

The Milken Institute's Asia Summit and TOKEN2049 in Singapore highlighted the importance of diversifying investments into Asia, particularly China, due to potential growth opportunities. Experts discussed the disruption in global trade, the need for diverse recruitment strategies, and the evolving crypto landscape. AON PLC and Goldman Sachs were mentioned in the context of recruitment and investment strategies.

Portfolio Pulse from Renato Capelj

September 30, 2024 | 12:35 pm

KZR

Kezar Life Sciences has voluntarily stopped enrollment and dosing in its Phase 2b PALIZADE trial of Zetomipzomib for active lupus nephritis patients. This decision could impact the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:35 pm

MBOT

Microbot Medical has accelerated the enrollment rate in its ACCESS-PVI trial, with 80% of patients having completed the follow-up period. The company is on track for an FDA 510(k) submission by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:35 pm

ANIX

Anixa Biosciences has submitted an amendment to its CAR-T trial protocol, allowing a second dose of CAR-T therapy for suitable patients. This development could enhance treatment efficacy and patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:33 pm

NBIX

Neurocrine Biosciences presented interim data showing significant and sustained improvements in chorea associated with Huntington's Disease through week 104, regardless of antipsychotic use.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:33 pm

ASND

Ascendis Pharma presented 3-year data at ASBMR 2024, demonstrating that long-term treatment with TransCon PTH normalizes bone remodeling in adults with hypoparathyroidism.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:33 pm

GRI

GRI Bio has been granted a patent in Japan for a treatment related to inflammatory conditions, which could enhance its intellectual property portfolio and potentially lead to new market opportunities.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:32 pm

F

Ford Motor Co. has launched the 'Ford Power Promise' program to boost EV sales by addressing 'change anxiety' among customers. The program offers benefits like free home-charging installation and aims to educate new EV owners.

Portfolio Pulse from Benzinga Neuro

September 30, 2024 | 12:32 pm

RDGL

Vivos Inc. has expanded its IsoPet Precision Radionuclide Therapy to include exotic animals. This expansion could potentially increase the company's market reach and revenue streams.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:31 pm

WINT

Windtree Therapeutics reported that serious adverse events related to worsening heart failure occurred less frequently in patients treated with Istaroxime compared to those given a placebo. The rates were 5.3% for the Istaroxime group versus 18.2% for the placebo group.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:21 pm